Gene therapy restores vision in a canine model of childhood blindness
- PMID:11326284
- DOI: 10.1038/ng0501-92
Gene therapy restores vision in a canine model of childhood blindness
Abstract
The relationship between the neurosensory photoreceptors and the adjacent retinal pigment epithelium (RPE) controls not only normal retinal function, but also the pathogenesis of hereditary retinal degenerations. The molecular bases for both primary photoreceptor and RPE diseases that cause blindness have been identified. Gene therapy has been used successfully to slow degeneration in rodent models of primary photoreceptor diseases, but efficacy of gene therapy directed at photoreceptors and RPE in a large-animal model of human disease has not been reported. Here we study one of the most clinically severe retinal degenerations, Leber congenital amaurosis (LCA). LCA causes near total blindness in infancy and can result from mutations in RPE65 (LCA, type II; MIM 180069 and 204100). A naturally occurring animal model, the RPE65-/- dog, suffers from early and severe visual impairment similar to that seen in human LCA. We used a recombinant adeno-associated virus (AAV) carrying wild-type RPE65 (AAV-RPE65) to test the efficacy of gene therapy in this model. Our results indicate that visual function was restored in this large animal model of childhood blindness.
Similar articles
- Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness.Acland GM, Aguirre GD, Bennett J, Aleman TS, Cideciyan AV, Bennicelli J, Dejneka NS, Pearce-Kelling SE, Maguire AM, Palczewski K, Hauswirth WW, Jacobson SG.Acland GM, et al.Mol Ther. 2005 Dec;12(6):1072-82. doi: 10.1016/j.ymthe.2005.08.008. Epub 2005 Oct 14.Mol Ther. 2005.PMID:16226919Free PMC article.
- Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation.Aguirre GK, Komáromy AM, Cideciyan AV, Brainard DH, Aleman TS, Roman AJ, Avants BB, Gee JC, Korczykowski M, Hauswirth WW, Acland GM, Aguirre GD, Jacobson SG.Aguirre GK, et al.PLoS Med. 2007 Jun;4(6):e230. doi: 10.1371/journal.pmed.0040230.PLoS Med. 2007.PMID:17594175Free PMC article.
- Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis.Jacobson SG, Boye SL, Aleman TS, Conlon TJ, Zeiss CJ, Roman AJ, Cideciyan AV, Schwartz SB, Komaromy AM, Doobrajh M, Cheung AY, Sumaroka A, Pearce-Kelling SE, Aguirre GD, Kaushal S, Maguire AM, Flotte TR, Hauswirth WW.Jacobson SG, et al.Hum Gene Ther. 2006 Aug;17(8):845-58. doi: 10.1089/hum.2006.17.845.Hum Gene Ther. 2006.PMID:16942444
- RPE65: role in the visual cycle, human retinal disease, and gene therapy.Cai X, Conley SM, Naash MI.Cai X, et al.Ophthalmic Genet. 2009 Jun;30(2):57-62. doi: 10.1080/13816810802626399.Ophthalmic Genet. 2009.PMID:19373675Free PMC article.Review.
- Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy.Cideciyan AV.Cideciyan AV.Prog Retin Eye Res. 2010 Sep;29(5):398-427. doi: 10.1016/j.preteyeres.2010.04.002. Epub 2010 Apr 24.Prog Retin Eye Res. 2010.PMID:20399883Free PMC article.Review.
Cited by
- Preclinical Development of Autologous Hematopoietic Stem Cell-Based Gene Therapy for Immune Deficiencies: A Journey from Mouse Cage to Bed Side.Garcia-Perez L, Ordas A, Canté-Barrett K, Meij P, Pike-Overzet K, Lankester A, Staal FJT.Garcia-Perez L, et al.Pharmaceutics. 2020 Jun 13;12(6):549. doi: 10.3390/pharmaceutics12060549.Pharmaceutics. 2020.PMID:32545727Free PMC article.Review.
- Improvement in vision: a new goal for treatment of hereditary retinal degenerations.Jacobson SG, Cideciyan AV, Aguirre GD, Roman AJ, Sumaroka A, Hauswirth WW, Palczewski K.Jacobson SG, et al.Expert Opin Orphan Drugs. 2015 May 4;3(5):563-575. doi: 10.1517/21678707.2015.1030393.Expert Opin Orphan Drugs. 2015.PMID:26246977Free PMC article.
- Dawn of ocular gene therapy: implications for molecular diagnosis in retinal disease.Zaneveld J, Wang F, Wang X, Chen R.Zaneveld J, et al.Sci China Life Sci. 2013 Feb;56(2):125-33. doi: 10.1007/s11427-013-4443-y. Epub 2013 Feb 8.Sci China Life Sci. 2013.PMID:23393028Free PMC article.Review.
- ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells.Lee J, Lee H, Lee H, Shin M, Shin MG, Seo J, Lee EJ, Park SA, Park S.Lee J, et al.Nat Commun. 2023 Dec 20;14(1):8463. doi: 10.1038/s41467-023-44319-3.Nat Commun. 2023.PMID:38123547Free PMC article.
- Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success.Jacobson SG, Aleman TS, Cideciyan AV, Sumaroka A, Schwartz SB, Windsor EA, Traboulsi EI, Heon E, Pittler SJ, Milam AH, Maguire AM, Palczewski K, Stone EM, Bennett J.Jacobson SG, et al.Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6177-82. doi: 10.1073/pnas.0500646102. Epub 2005 Apr 18.Proc Natl Acad Sci U S A. 2005.PMID:15837919Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials